Indraprastha Medical Corporation Limited (INDRAMEDCO) fundamentals
Indraprastha Medical Corporation Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as INDRAMEDCO (ISIN INE681B01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Indraprastha Medical Corporation Limited does
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
Valuation and market data
| Last close | ₹355.00 |
|---|---|
| Market capitalisation | ₹3,255 crore |
| Enterprise value | ₹3,269 crore |
| P/E (TTM) | 0.00 |
| Price to book | 5.45 |
| Price to sales (TTM) | 2.09 |
| Book value per share | ₹65.08 |
| Dividend yield | 126.76% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Thu Apr 17 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,511 crore | ₹246 crore | ₹184 crore | 0.00 |
| Mar 2025 | ₹1,379 crore | ₹216 crore | ₹161 crore | 17.56 |
| Mar 2024 | ₹1,262 crore | ₹166 crore | ₹124 crore | 13.52 |
| Mar 2023 | ₹1,109 crore | ₹117 crore | ₹86 crore | 9.40 |
| Mar 2022 | ₹891 crore | ₹79 crore | ₹59 crore | 6.39 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 51.0% |
|---|---|
| Foreign institutions (FII) | 2.8% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.6% |
| Retail and others | 45.6% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.